⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

SEER

Seer, Inc.

Healthcare · Biotechnology

1.94USD

-0.0100 (-0.51%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY15.5M16.7M14.2M16.6M16.1M19.4M
Q13.3M4.1M3.1M4.2M2.8M—
Q23.6M4.0M3.1M4.1M3.1M—
Q34.0M4.2M4.0M4.1M4.2M—
Q44.6M*4.4M*4.0M*4.2M*6.1M—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY-1.49-1.35——-1.10-1.02
Q1-.380-.380-.320———
Q2-.370-.370-.350———
Q3-.380-.330-.350—-.260—
Q4-.361*

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

-.279*
—
—
-.220
—